期刊文献+

多种HIVB′/C亚型基因在复制型DNA疫苗中表达及免疫效果研究 被引量:1

Expression and Immunity of Multi-HIV B'/C Subype Genes in Replicating DNA Vaccines
原文传递
导出
摘要 为了解多种HIVB′/C亚型基因在复制型DNA疫苗中表达水平及对免疫效果影响,使用复制型DNA疫苗载体pSCK2,分别构建了7种含单种或多种HIVB′/C亚型基因gagpol、gp160和rtn(rev、tat和nef融合基因)的DNA疫苗质粒。免疫荧光检测表明,Gag、Gp160、Rev、Tat和Nef蛋白均能从相应7种DNA疫苗中表达,单基因表达质粒中的基因表达水平和双基因表达质粒中IRES上游的基因表达水平普遍较好。小鼠免疫后,Gag能诱发较高的抗体滴度,Gp160、Pol和RTN的抗体滴度很低;比较研究显示,Gag单独表达和Gag与RTN双表达的质粒均能诱发较好的Gag抗体反应,但Gag与Gp160双表达质粒免疫或含Gag、Gp160和RTN质粒联合免疫的Gag抗体反应均较弱。ELISPOT检测表明,7种DNA疫苗单独或不同组合方式免疫均能诱发针对Gag、Pol、Gp160、Tat和Nef的细胞免疫反应;单基因表达质粒单独免疫诱发的细胞免疫反应最好,含gagpol和gp160双基因表达质粒单独免疫或与含其它基因质粒联合免疫诱发的Gag、Pol和Gp160细胞免疫明显低于含Gagpol或Gp160单基因质粒诱发的相应免疫反应,但诱发的Tat和Nef细胞免疫与相应单基因质粒免疫组无明显差别。本研究结果显示,不同表达构建体的多种HIVB'/C亚型的基因gagpol、gp160和rtn均能从pSCK2质粒中较好地表达;不同基因结构和不同组合免疫的优化,特别是含gag和gp160基因疫苗联合免疫程序的进一步优化对提高其免疫效果是必要的。 To understand the effect of various gene structures of HIV B'/C subtype on the gene expression and immunity in DNA vaccine,replicating DNA vector pSCK2 was used to construct seven DNA vaccines carrying one or more of HIV B'/C subtype genes:gagpol,gp160 and rtn (rev、tat and nef fusion gene). Immunofluorescence staining indicated that Gag,Gp160,Rev,Tat and Nef could be expressed from the seven DNA vaccines. Stronger expression was observed with the gene in single-gene expression plasmid or with the gene located at upper-IRES in double-or multi-gene expression plasmid. ELISA test showed that Gag induced higher antibody response,but the antibody titers stimulated by Gp160,Pol,or RTN were very low. Both Gag single-gene expression plasmid and Gag-RTN double-gene expression plasmid separately inoculating induced stronger antibody response against Gag than Gag-Gp160 double-gene expression plasmid and Gagpol-Gp160-RTN multi-gene expression plasmid or combined inoculation of Gag and Gp160 single-gene expression plasmids did. ELISPOT detection showed that all the seven DNA vaccines could stimulate cellular immune response against Gag,Pol,Gp160,Tat,and Nef,respectively. Gagpol or Gp160 single-gene expression plasmid separately inoculating stimulated the strongest cellular immune response. Tat and Nef expressed in all the plasmids induced similar immune response. These results indicated that HIV B'/C subtype genes gagpol,gp160 and rtn could be efficiently expressed in the replicating DNA vaccine vector,single-gene expression plasmid had the higher gene expression level and induced stronger immune response; combined immunization of Gagpol and Gp160 had dramatically lower immunity than Gagpol or Gp160 separated immunization did. Immunity of RTN had no difference between combined and separated immunizations. Therefore,in case of immunization with DNA vaccines containing different HIV genes,it is necessary to optimize the combined immunization procedure,especially for the combination of Gag and Gp160-containing vacc
出处 《病毒学报》 CAS CSCD 北大核心 2010年第3期208-215,共8页 Chinese Journal of Virology
基金 CIPRA项目(1U19A15191501) 863项目(2003AA219080) "十一.五"重大专项(2008ZX10001-012)
关键词 HIV-1DNA疫苗 复制子 体液免疫 细胞免疫 HIV DNA vaccine gene expression humoral immunity cellular immunity
  • 相关文献

参考文献15

  • 1Woodland D L. Jump-starting the immune system: prime-boosting comes of age [J] Trends Immunol, 2004, 25(2) :98-104. 被引量:1
  • 2Xiao S, Chen H, Fang L, et al. Comparison of immune responses and protective efficacy of suicidal DNA vaccine and conventional DNA vaccine encoding glycoprorein C of pseudorabies virus in mice[J]. Vaccine, 2004, 22(3-4): 345-351. 被引量:1
  • 3Kim T W, Hung C F, Juang J, et al. Enhancement of suicidal DNA vaccine potency by delaying suicidal DNA-induced cell death[J]. Gene Ther, 2004, 11(3): 336-342. 被引量:1
  • 4DiCiommo D P, Bremner R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors[J]. J Biol Chem, 1998, 273(29):18060-18066. 被引量:1
  • 5齐香荣,高瑛瑛,邓瑶,等.ELISPOT方法筛选HIV-1B/C亚型六种抗原的H-2d限制的CTL表位肽[J].待发表. 被引量:1
  • 6Estcourt M J, McMichael A J T Hanke, DNA vaccines against human immunodeficiency virus type 1[J]. Immunol Rev, 2004, 199(1) :141-155. 被引量:1
  • 7Ellenberger D, Li B, Smith J, et al. Optimization of a multi-gene HIV-1 recombinant subtype CRF02_ AG DNA vaccine for expression of multiple immunogenie forms[J]. Virology, 2004, 319(1): 118-130. 被引量:1
  • 8Driver D A, Latham E M, Polo J M, et al. Layered amplification of gene expression with a DNA gene delivery system [J]. Ann N Y Acad Sci, 1995, 27(772):261- 264. 被引量:1
  • 9张健慧,Jens Wild,Kurt Bieler,Marcus Graf,Ludwig Deml,Hans Wolf,PeterLiljestrm,Ralf Wagner,邵一鸣.传统DNA疫苗载体与Semliki森林病毒复制子对HIV-1 Pr55^(gag)表达与体液免疫原性的比较性研究[J].病毒学报,2002,18(1):1-8. 被引量:13
  • 10Amara R R, Smith J M, Staprans S I, et al. Critical role for Env as well as Gag-Pol in control of a simianhuman immunodeficiency virus 89. 6P challenge by a DNA prime/recombinant modified vaecinia virus Ankara vaccine[J]. J Virol, 2002, 76(12):6138-6146. 被引量:1

二级参考文献26

  • 1Deml L;Schirmbeck R;Peimann J.Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp160 envelope proteins[J],1999(03). 被引量:1
  • 2Wang B;Boyer J;Srikantan V.DNA inoculation induces neutralizing immune responses against human immunodeficiency virus type 1 in mice and nonhuman primates[J],1993(09). 被引量:1
  • 3Strugnell R A;Drew D;Mercieca J.DNA vaccines for bacterial infections[J],1997(04). 被引量:1
  • 4Hedstrom R C;Doolan D L;Wang R.The development of a multivalent DNA vaccine for malaria[J],1997(02). 被引量:1
  • 5LUNDHOLM P;Asakura Y;Hinkula J.Induction of mucosal IgA by a novel jet delivery technique for HIV-1 DNA[J],1999(15-16). 被引量:1
  • 6Haigwood N L;Pierce C C;Robertson M N.Protection from pathogenic SIV challenge using multigenic DNA vaccines[J],1999(1-3). 被引量:1
  • 7MOSSMAN S P;Pierce C C;Robertson M N.Immunization against SIVmne in macaques using multigenic DNA vaccines,1999(28). 被引量:1
  • 8Letvin N L;Montefiori D C;Yasutomi Y.Potent,protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination[J],1997(17). 被引量:1
  • 9Billaut Mulot O;Idziorek T;Loyens M.Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost[J],2001(20/22). 被引量:1
  • 10Vinner L;Nielsen H V;Bryder K.Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons[J],1999(17). 被引量:1

共引文献12

同被引文献29

  • 1Wender C M,Kofler D M,Mayr C. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors[J].Leukemia and Lymphoma,2004,(05):897-904. 被引量:1
  • 2Cignetti A,Vallario A,Roato I. Leukemia-derived immature dendritic cells differentiate into functionally competent mature dendritic cells that efficiently stimulate T cell responses[J].Journal of Immunology,2004,(04):2855-2865. 被引量:1
  • 3Sadovnikova E;Parovichnikova E N;Semikina E 于 L.Adhesion capacity and integrin expression by dendriticlike cells generated from acute myeloid leukemia blasts by calcium ionophore treatment[J],Experimental Hematology2004(06):563-570. 被引量:1
  • 4Kipps T J. Immune and cell therapy of hematologic malignancies[J].International Journal of Hematology,2002,(Suppl 1):269-273. 被引量:1
  • 5Zhang Wanggang,Liu Suhu,Cao Xinmei. A phase-Ⅰ clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2,GM-CSF,and IL-6[J].Leukemia Research,2005,(01):3-9.doi:10.1016/j.leukres.2004.04.015. 被引量:1
  • 6Spaner D E,Hammond C,Mena J. A phase Ⅰ/Ⅱ trial of oxidized autologous tumor vaccines during the "watch and wait" phase of chronic lymphocytic leukemia[J].Cancer Immunology Immunotherapy,2005,(07):635-646. 被引量:1
  • 7Pinilla Ibarz J,Cathcart K,Scheinberg D A. CML vaccines as a paradigm of the specific immunotherapy of cancer[J].Blood Reviews,2000,(02):111-120. 被引量:1
  • 8Rosenfeld C,Cheever M A,Gaiger A. WT1 in acute leukemia,chronic myelogenous leukemia and myelodysplastic syndrome:therapeutic potential of WT1 targeted therapies[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2003,(07):1301-1312. 被引量:1
  • 9Cathcart K,Pinilla-Ibarz J,Korontsvit T. A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia[J].Blood,2004,(03):1037-1042. 被引量:1
  • 10Pinilla-Ibarz J,Cathcart K,Korontsvit T. Vaccination of patients with chronic myelogenous leukemia with bcrabl oncogene breakpoint fusion peptides generates specific immune responses[J].Blood,2000,(05):1781-1787. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部